Diazoxide Suppression Test P&F Study

Diazoxide Suppression Test P&F Study

Conditions: Insulin Resistance; Hyperinsulinemia; Obesity
Interventions: Drug: Diazoxide, 3 mg/kg per dose
Sponsors: Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pisa
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 12, 2025Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments